Treatment of metastatic bone pain with strontium-89

Blake G. M. (1986) Personal Communication Blake, 1986, Sr-89 therapy: Stontium kinetics in disseminated carcinoma of the prostate, Eur. J. Nucl. Med., 10.1007/BF00254749 Brucer, 1976, A history of bone scanning, 16 Firusian, 1976, Results of 89Strontium therapy in patients with carcinoma of the prostate and incurable pain from bone metastases: A preliminary report, J. Urol., 116, 764, 10.1016/S0022-5347(17)59002-3 Lawrence, 1950, Multiple myeloma: A study of 24 patients treated with radioactive isotopes (P32 and Sr89), Ann. Intern. Med., 33, 41, 10.7326/0003-4819-33-1-41 Mauch, 1982, Treatment of metastic cancer to bone, 1564 Maxfield, 1958, The use of radiocative phosphorus and testosterone in metastatic bone lesions from breast and prostate, Southern Med. J., 51, 320, 10.1097/00007611-195803000-00009 McEwan, 1986, Sr-89 Therapy: Clinical response in metastatic bone disease, Nucl. Med. Commun., 7, 293 Pecher, 1942, Biological investigations with radioactive calcium and strontium: Preliminary report on the use of radioactive strontium in treatment of metastatic bone cancer, 11, 117 Robinson, 1983, Palliation of metastic cancer to bone with strontium-89, J. Nucl. Med., 24, 57 Robinson, 1986, Radionuclides for the alleviation of bone pain in advanced maliganancy, Clin. Oncol., 5, 39 Silberstein, 1985, Strontium-89 therapy for the pain of osseous metastases, J. Nucl. Med., 26, 345 Subramanian, 1983, New diphosphonate compounds for skeletal imaging: Comparison with methylene diphosphonate, Radiology, 149, 823, 10.1148/radiology.149.3.6316414